Advertisement

Topics

FDA grants orphan status to Syros' acute myeloid leukemia candidate

05:28 EDT 23 Aug 2017 | SmartBrief

Syros Pharmaceuticals said its lead drug candidate, SY-1425, developed as a treatment for patients with acute myeloid leukemi -More

Original Article: FDA grants orphan status to Syros' acute myeloid leukemia candidate

NEXT ARTICLE

More From BioPortfolio on "FDA grants orphan status to Syros' acute myeloid leukemia candidate"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...